4 versions

CosmeticWhat changed in ENROLLED BILLcompared with ENGROSSED IN SENATE (Aug 6, 2026)

Technical corrections only. The differences between v3 and v4 are limited to the legislative boilerplate and formatting related to the bill's progression from Engrossed in Senate to Enrolled. No substantive policy changes were made to the text of the Kay Hagan Tick Reauthorization Act itself.

S. 2398119th CongressIntroduced Jul 23, 2025

Kay Hagan Tick Reauthorization Act

Passed SenateHealthNarrow

View bill text

Sponsor: Sen. Collins, Susan M. [R-ME]
Committees: Health, Education, Labor, and Pensions Committee (primary)
Last action: Sep 15, 2026

This analysis was written for v3 (ENGROSSED IN SENATE, Aug 6, 2026). ENROLLED BILL changed too little to need its own, so it reuses that one rather than a rewrite. The differences between the two are summarized above. View v3

Bottom line

The bill extends federal funding authorization for programs addressing vector-borne diseases for an additional five years, ensuring continued support for research, surveillance, and public health efforts.

What it actually does

This bill reauthorizes federal programs related to vector-borne diseases, including the national strategy and regional centers of excellence, and enhanced support for health departments. It extends the authorization for appropriations for these programs from fiscal years 2021-2025 to 2026-2030. Additionally, it makes a minor technical change regarding the coordination of the national strategy, replacing a specific working group with a more general reference to "appropriate individuals."

Section 2(a)(3)

Reauthorization of National Strategy and Regional Centers of Excellence in Vector-borne Diseases

prominently featuredstraightforward

This provision extends the authorization for appropriations for programs focused on developing a national strategy and establishing regional centers of excellence for vector-borne diseases. It shifts the funding period from fiscal years 2021 through 2025 to fiscal years 2026 through 2030. This ensures continued federal financial support for research, surveillance, and coordination efforts aimed at combating diseases transmitted by vectors like ticks and mosquitoes.

Section 2(b)

Reauthorization of Enhanced Support to Health Departments for Vector-borne Diseases

prominently featuredstraightforward

This provision extends the authorization for appropriations for programs that provide enhanced support to state and local health departments to address vector-borne diseases. The funding period is moved from fiscal years 2021 through 2025 to fiscal years 2026 through 2030. This ensures that health departments can continue to receive federal assistance for activities such as disease surveillance, prevention campaigns, and public health responses to outbreaks of vector-borne illnesses.

FOUND

This provision amends the Public Health Service Act to modify the language regarding the coordination of the national strategy for vector-borne diseases. Specifically, it removes the explicit mention of the 'Tick-Borne Disease Working Group' and replaces it with 'appropriate individuals' in subsection (b). It also changes 'in coordination with' to 'acting through' in subsection (c).

Section 2(a)(1) and (2)

Why it matters:This is standard legislative practice for updating statutory language to provide greater administrative flexibility. It allows the Secretary of Health and Human Services to determine the most effective coordination mechanisms without requiring further legislative amendments if specific groups or their roles change. It is not intended to be evasive.

Case for: Supporters would argue that this change provides greater flexibility for the Department of Health and Human Services to adapt its coordination efforts for the national strategy, allowing it to engage the most relevant and current experts or bodies without needing a new legislative act. It streamlines administrative processes.

Case against: Critics might contend that removing the specific reference to the 'Tick-Borne Disease Working Group' could potentially dilute the dedicated focus on tick-borne diseases or reduce transparency regarding which specific entities are responsible for coordinating the national strategy.

Estimated impact: The direct fiscal impact is minimal. The impact is primarily administrative, affecting how the national strategy for vector-borne diseases is coordinated and potentially who is involved in its development and oversight.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

CosmeticWhat changed in ENROLLED BILLcompared with ENGROSSED IN SENATE (Aug 6, 2026)

S. 2398119th CongressIntroduced Jul 23, 2025

Kay Hagan Tick Reauthorization Act

Passed SenateHealthNarrow

View bill text

Sponsor: Sen. Collins, Susan M. [R-ME]
Committees: Health, Education, Labor, and Pensions Committee (primary)
Last action: Sep 15, 2026

Bottom line

What it actually does

Section 2(a)(3)

Reauthorization of National Strategy and Regional Centers of Excellence in Vector-borne Diseases

prominently featuredstraightforward

Section 2(b)

Reauthorization of Enhanced Support to Health Departments for Vector-borne Diseases

prominently featuredstraightforward

FOUND

Section 2(a)(1) and (2)